Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05856942 · ClinicalTrials.gov registry record · NA
Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program
A NA study of HIV Prevention and Pre-exposure Prophylaxis, sponsored by University of Washington.
- Recruiting
- Registry status
- NA
- Development phase
- 458
- Enrollment target
- 1
- Study location
NCT05856942: Recruiting NA study of HIV Prevention and Pre-exposure Prophylaxis, sponsored by University of Washington.
NCT05856942 is a NA study of HIV Prevention and Pre-exposure Prophylaxis that is actively recruiting participants, run by University of Washington. The registered enrollment target is 458 participants, above the 368-participant average among 32 other HIV Prevention trials with a reported enrollment target (24% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05856942, a NA study of HIV Prevention and Pre-exposure Prophylaxis, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- NA
- Development phase
- 458 participants
- Enrollment target
- 1
- Study location
Study Summary
The study's aim is to implement a home-based PrEP (HB-PrEP) monitoring system (self-collected blood and extragenital specimens at home and telehealth follow-up) into a large, urban sexual health clinic while also evaluating the program's clinical effectiveness. Study participants will self-collect blood specimens using Tasso devices, which are currently designated as FDA Class 2 exempt medical devices (similar to a medical lancet). This study will be integrated into King County's Ending the HIV Epidemic plan and generate data to inform refinement, adaptation and scale-up of future HB-PrEP programs. Specific research aims are to: 1. Conduct a hybrid randomized trial to compare the impact of a HB-PrEP program versus standard of care (routine in-clinic monitoring) on PrEP retention over time and use mixed-methods assessments to define the factors that influence HB-PrEP implementation. Hypothesis: HB-PrEP will increase PrEP retention rates by \>10% at 18 months and 60% of those offered HB-PrEP will use it for over half of visits. 2. Perform a cost analysis of the HB-PrEP implementation strategy compared to standard care. Hypothesis: HB-PrEP cost will fall within the HIV prevention budget and be affordable with comparable costs to SOC. 3. Develop a qualitative tool to engage healthcare stakeholders and determine the wider scalability of HB-PrEP.
Conditions Studied
Interventions
- OTHER Health service - home-based PrEP monitoring
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 458 participants |
| Start Date | 2022-03-08 |
| Est. Completion | 2025-09-08 |
| Phase | NA |
What NCT05856942 shows while recruiting
NCT05856942 is an interventional study that assigns participants to a tested intervention. The registered 458 participants enrollment target is mid-sized for trials with a published cap, above the 368-participant average among 32 other HIV Prevention trials with a reported enrollment target (24% higher).
The record links to 3 conditions, with HIV Prevention appearing as the primary indexed condition, and to 1 intervention - of which Health service - home-based PrEP monitoring is the first listed.
NCT05856942 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT05856942 about?
NCT05856942 is a clinical study titled "Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program". The study's aim is to implement a home-based PrEP (HB-PrEP) monitoring system (self-collected blood and extragenital specimens at home and telehealth follow-up) into a large, urban sexual health clinic while also evaluating the program's clinical effectiveness. Study participants will self-collect b...
What is the current status of trial NCT05856942?
This trial is currently recruiting. It is a NA study. The enrollment target is 458 participants. The study started on 2022-03-08. Estimated completion is 2025-09-08.
What conditions does trial NCT05856942 study?
This clinical trial studies the following conditions: HIV Prevention, Pre-exposure Prophylaxis, STI.
What interventions are being tested in trial NCT05856942?
The interventions under investigation include: Health service - home-based PrEP monitoring (OTHER).
Who is sponsoring clinical trial NCT05856942?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05856942 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Prevention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05856942's enrollment target sits among peer trials
458 5th of 32 higher than 28 of 32 other HIV Prevention trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Prevention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Using PrEP, Doing It for Ourselves
RECRUITING · NA
-
Client-Centered Care Coordination for Black Men Who Have Sex With Men
RECRUITING · NA
-
Behavioral Economic Intervention to Improve HIV Behaviors in Sexual Minority Individuals
RECRUITING · NA
-
Intervention to Enhance PrEP Persistence
RECRUITING · NA
-
WePrEP: Developing a PrEP Shared Decision-making Tool for Transgender Women
RECRUITING · NA
-
Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06201676 · 458 participants · Phase 4
Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients
- NCT04452825 · 459 participants · NA
A New Psychotherapy Intervention for Older Cancer Patients
- NCT02977780 · 460 participants · Phase 2
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
- NCT03427736 · 460 participants
Anesthetics and Analgesics in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI